Biomedix

%COMPANYNAME%, We wanted to introduce PADnet®, a non-invasive vascular testing solution designed to help providers identify peripheral artery disease (PAD) earlier and more efficiently. PADnet® supports fast, reimbursable testing workflows that can help improve patient outcomes and streamline vascular screening within primary care and specialty practices. We would be happy to schedule a complimentary consultation to discuss how PADnet® may fit within your organization’s care model. Thank you, Team Biomedix

We help practices identify high-risk and clinically indicated patients who may benefit from PAD screening and vascular assessment. Our team can perform a no-obligation patient population analysis to uncover screening opportunities, support quality initiatives, and help improve early disease identification within your practice. If you’d like to see what opportunities may already exist within your patient population, please reach out for a complimentary consultation. Thank you, Team Biomedix

Biomedix's PADnet is your partner in detecting vascular conditions like peripheral artery disease and chronic venous insufficiency efficiently. With its unique collaborative care model, you can provide cost-effective treatment while improving patient health outcomes. Experience the future of diagnostic technology today. Thank you, Team Biomedix

Join countless healthcare professionals who trust Biomedix’s cutting-edge tools for diagnosing vascular diseases such as PAD and CVI. Our solutions ensure seamless collaboration between specialists, ensuring timely interventions that save lives while maintaining affordability. Thank you, Team Biomedix

We at Biomedix are committed to enhancing healthcare delivery through our mobile health assessment platform and advanced diagnostic devices like PADnet. By centralizing data across multiple chronic conditions, we help you analyze population health effectively for better decision-making and improved patient care. Thank you, Team Biomedix

%COMPANYNAME%, We help practices identify high-risk and clinically indicated patients who may benefit from PAD screening and vascular assessment. Our team can perform a no-obligation patient population analysis to uncover screening opportunities, support quality initiatives, and help improve early disease identification within your practice. If you’d like to see what opportunities may already exist within your patient population, please reach out for a complimentary consultation. Thank you, Team Biomedix